{
  "company": {
    "name": "ImmunoVec",
    "website": "https://immunovec.com/",
    "record": "https://startuphistory.org/c/immunovec.com"
  },
  "status": null,
  "history_since": "2021-02-27T17:49:38.000Z",
  "baseline": {
    "snapshot_id": "135cf66b33256f065d84b6caf0ca0c47a44d790b41b1504d2b6929a752faec05",
    "observed_at": "2021-02-27T17:49:38.000Z",
    "headline": "Gene Therapy for Hematopoietic Diseases",
    "description": null,
    "evidence": "https://web.archive.org/web/20210227174938/https://www.immunovec.com/",
    "evidence_kind": "internet_archive",
    "facts": null,
    "basis": "first_observation",
    "is_change": false
  },
  "live_captures": 1,
  "last_checked": "2026-11-06T17:22:41.701Z",
  "live_status": null,
  "messaging": [
    {
      "quote_observed_at": "2025-07-17T08:22:23.000Z",
      "variants": [
        {
          "headline": "Gene Therapy for Hematopoietic Diseases",
          "subhead": null,
          "observed_at": "2021-02-27T17:49:38.000Z",
          "evidence": "https://web.archive.org/web/20210227174938/https://www.immunovec.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Gene Therapy for Hematopoietic Diseases",
          "subhead": null,
          "observed_at": "2021-07-31T07:46:41.000Z",
          "evidence": "https://web.archive.org/web/20210731074641/https://www.immunovec.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Gene Therapy for Hematopoietic Diseases",
          "subhead": null,
          "observed_at": "2022-01-29T09:26:43.000Z",
          "evidence": "https://web.archive.org/web/20220129092643/https://www.immunovec.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Gene Therapy for Hematopoietic Diseases",
          "subhead": null,
          "observed_at": "2022-07-03T07:39:40.000Z",
          "evidence": "https://web.archive.org/web/20220703073940/https://www.immunovec.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Gene Therapy for Hematopoietic Diseases",
          "subhead": null,
          "observed_at": "2023-02-01T21:49:18.000Z",
          "evidence": "https://web.archive.org/web/20230201214918/https://www.immunovec.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Gene Therapy for Hematopoietic Diseases",
          "subhead": null,
          "observed_at": "2024-06-22T05:03:39.000Z",
          "evidence": "https://web.archive.org/web/20240622050339/https://www.immunovec.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Gene Therapy for Hematopoietic Diseases",
          "subhead": null,
          "observed_at": "2024-07-24T23:28:08.000Z",
          "evidence": "https://web.archive.org/web/20240724232808/https://www.immunovec.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Gene Therapy for Hematopoietic Diseases",
          "subhead": null,
          "observed_at": "2025-02-07T16:43:30.000Z",
          "evidence": "https://web.archive.org/web/20250207164330/https://www.immunovec.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Gene Therapy for Hematopoietic Diseases",
          "subhead": null,
          "observed_at": "2025-07-17T08:22:23.000Z",
          "evidence": "https://web.archive.org/web/20250717082223/https://www.immunovec.com/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "Gene Therapy for Hematopoietic Diseases",
      "subhead": null,
      "from": "2021-02-27T17:49:38.000Z",
      "to": "2025-07-17T08:22:23.000Z",
      "captures": 9,
      "evidence": "https://web.archive.org/web/20250717082223/https://www.immunovec.com/",
      "evidence_kind": "internet_archive",
      "seen": {
        "between": {
          "from": "2021-02-27T17:49:38.000Z",
          "to": "2025-07-17T08:22:23.000Z"
        }
      },
      "current": false
    },
    {
      "quote_observed_at": "2026-01-22T15:31:32.000Z",
      "variants": [
        {
          "headline": "At ImmunoVec, we develop in vivo therapies to precisely engineer any targeted cell type within the human body.",
          "subhead": "At ImmunoVec, we develop in vivo therapies to precisely engineer any targeted cell type within the human body.",
          "observed_at": "2026-01-22T15:31:32.000Z",
          "evidence": "https://web.archive.org/web/20260122153132/https://immunovec.com/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "At ImmunoVec, we develop in vivo therapies to precisely engineer any targeted cell type within the human body.",
      "subhead": "At ImmunoVec, we develop in vivo therapies to precisely engineer any targeted cell type within the human body.",
      "from": "2026-01-22T15:31:32.000Z",
      "to": "2026-01-22T15:31:32.000Z",
      "captures": 1,
      "evidence": "https://web.archive.org/web/20260122153132/https://immunovec.com/",
      "evidence_kind": "internet_archive",
      "seen": {
        "on": "2026-01-22T15:31:32.000Z"
      },
      "current": false
    },
    {
      "quote_observed_at": "2026-11-06T17:22:41.701Z",
      "variants": [
        {
          "headline": "ImmunoVec is pioneering the next generation of precise, durable in vivo medicines for cancer and autoimmune disease",
          "subhead": "At ImmunoVec, we develop in vivo therapies to precisely engineer any targeted cell type within the human body.",
          "observed_at": "2026-11-06T17:22:41.701Z",
          "evidence": "https://immunovec.com/",
          "evidence_kind": "live_capture"
        }
      ],
      "headline": "ImmunoVec is pioneering the next generation of precise, durable in vivo medicines for cancer and autoimmune disease",
      "subhead": "At ImmunoVec, we develop in vivo therapies to precisely engineer any targeted cell type within the human body.",
      "from": "2026-11-06T17:22:41.701Z",
      "to": "2026-11-06T17:22:41.701Z",
      "captures": 1,
      "evidence": "https://immunovec.com/",
      "evidence_kind": "live_capture",
      "seen": {
        "on": "2026-11-06T17:22:41.701Z"
      },
      "current": true
    }
  ],
  "changes": [
    {
      "n": 1,
      "id": "page-df948836d70cf28aa8941a87e126945feba5e49a349145d8ce1b681288acfdd1:fe12126673ad6eef7113d9ae4a128820880ba1aa81a5a56f185c7772326bfcd6:headline:628e43c9ebddf33b",
      "before_evidence": "https://web.archive.org/web/20250717082223/https://www.immunovec.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "headline",
      "label": "Headline",
      "summary": "Changed its homepage headline from “Gene Therapy for Hematopoietic Diseases” to “At ImmunoVec, we develop in vivo therapies to precisely engineer any targeted cell type within the human body.”.",
      "between": {
        "from": "2025-07-17T08:22:23.000Z",
        "to": "2026-01-22T15:31:32.000Z"
      },
      "evidence": "https://web.archive.org/web/20260122153132/https://immunovec.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": null
    },
    {
      "n": 2,
      "id": "page-df948836d70cf28aa8941a87e126945feba5e49a349145d8ce1b681288acfdd1:fe12126673ad6eef7113d9ae4a128820880ba1aa81a5a56f185c7772326bfcd6:hiring:20dd4c09cc4ab0aa",
      "before_evidence": "https://web.archive.org/web/20250717082223/https://www.immunovec.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "hiring",
      "label": "Hiring",
      "summary": "Added a careers page.",
      "between": {
        "from": "2025-07-17T08:22:23.000Z",
        "to": "2026-01-22T15:31:32.000Z"
      },
      "evidence": "https://web.archive.org/web/20260122153132/https://immunovec.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": "https://startuphistory.org/t/added-careers-page"
    },
    {
      "n": 3,
      "id": "page-fe12126673ad6eef7113d9ae4a128820880ba1aa81a5a56f185c7772326bfcd6:bf5a8c05d4d78ca41f82ce545ec6f77422ae21049cbad241a144b89b73bab5fd:headline:842f458f9b88ef39",
      "before_evidence": "https://web.archive.org/web/20260122153132/https://immunovec.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "headline",
      "label": "Headline",
      "summary": "Changed its homepage headline from “At ImmunoVec, we develop in vivo therapies to precisely engineer any targeted cell type within the human body.” to “ImmunoVec is pioneering the next generation of precise, durable in vivo medicines for cancer and autoimmune disease”.",
      "between": {
        "from": "2026-01-22T15:31:32.000Z",
        "to": "2026-11-06T17:22:41.701Z"
      },
      "evidence": "https://immunovec.com/",
      "evidence_kind": "live_capture",
      "basis": "page_facts",
      "topic": null
    }
  ],
  "update": {
    "headline": "ImmunoVec updates positioning on in vivo medicines and adds careers page",
    "summary": "ImmunoVec has revised its homepage messaging twice and added a careers page. The latest homepage wording emphasizes precise, durable in vivo medicines for cancer and autoimmune disease.",
    "points": [
      {
        "text": "Between July 2025 and January 2026, ImmunoVec changed its homepage headline from “Gene Therapy for Hematopoietic Diseases” to a broader description of developing in vivo therapies to engineer targeted cell types in the human body.",
        "kind": "fact",
        "changes": [
          1
        ]
      },
      {
        "text": "Between July 2025 and January 2026, ImmunoVec added a careers page to its website.",
        "kind": "fact",
        "changes": [
          2
        ]
      },
      {
        "text": "Between January 2026 and November 2026, ImmunoVec changed its homepage headline to state that it is pioneering precise, durable in vivo medicines for cancer and autoimmune disease.",
        "kind": "fact",
        "changes": [
          3
        ]
      },
      {
        "text": "The sequence of homepage headline changes between July 2025 and November 2026 suggests ImmunoVec may be narrowing its public focus from hematopoietic diseases to in vivo medicines for cancer and autoimmune disease.",
        "kind": "interpretation",
        "changes": [
          1,
          3
        ]
      }
    ],
    "written_at": "2026-11-07T16:00:20.166Z",
    "basis": "ai_analysis",
    "model": "gpt-5.1-2025-11-13"
  },
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “ImmunoVec” company record, https://startuphistory.org/c/immunovec.com"
}